GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (OCSE:BAVA) » Definitions » Days Sales Outstanding

Bavarian Nordic A/S (OCSE:BAVA) Days Sales Outstanding : 54.82 (As of Dec. 2023)


View and export this data going back to 1998. Start your Free Trial

What is Bavarian Nordic A/S Days Sales Outstanding?

Bavarian Nordic A/S's average Accounts Receivable for the three months ended in Dec. 2023 was kr1,470 Mil. Bavarian Nordic A/S's Revenue for the three months ended in Dec. 2023 was kr2,447 Mil. Hence, Bavarian Nordic A/S's Days Sales Outstanding for the three months ended in Dec. 2023 was 54.82.

The historical rank and industry rank for Bavarian Nordic A/S's Days Sales Outstanding or its related term are showing as below:

OCSE:BAVA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 18   Med: 46.59   Max: 59.47
Current: 57.01

During the past 13 years, Bavarian Nordic A/S's highest Days Sales Outstanding was 59.47. The lowest was 18.00. And the median was 46.59.

OCSE:BAVA's Days Sales Outstanding is ranked better than
61.91% of 890 companies
in the Biotechnology industry
Industry Median: 71.92 vs OCSE:BAVA: 57.01

Bavarian Nordic A/S's Days Sales Outstanding increased from Dec. 2022 (41.63) to Dec. 2023 (54.82).


Bavarian Nordic A/S Days Sales Outstanding Historical Data

The historical data trend for Bavarian Nordic A/S's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic A/S Days Sales Outstanding Chart

Bavarian Nordic A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.56 18.00 50.09 52.41 59.47

Bavarian Nordic A/S Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.63 46.08 47.12 81.96 54.82

Competitive Comparison of Bavarian Nordic A/S's Days Sales Outstanding

For the Biotechnology subindustry, Bavarian Nordic A/S's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bavarian Nordic A/S's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bavarian Nordic A/S's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic A/S's Days Sales Outstanding falls into.



Bavarian Nordic A/S Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Bavarian Nordic A/S's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (523.145 + 1778.104) / 2 ) / 7062.34*365
=1150.6245 / 7062.34*365
=59.47

Bavarian Nordic A/S's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (1162.322 + 1778.104) / 2 ) / 2447.26*365 / 4
=1470.213 / 2447.26*365 / 4
=54.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bavarian Nordic A/S  (OCSE:BAVA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Bavarian Nordic A/S Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic A/S's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Bavarian Nordic A/S (OCSE:BAVA) Business Description

Traded in Other Exchanges
Address
Philip Heymans Alle 3, Hellerup, DNK, DK-2900
Bavarian Nordic A/S is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets.

Bavarian Nordic A/S (OCSE:BAVA) Headlines

No Headlines